TH1601000539A - Divalent vaccine components and their use for tumor therapy - Google Patents

Divalent vaccine components and their use for tumor therapy

Info

Publication number
TH1601000539A
TH1601000539A TH1601000539A TH1601000539A TH1601000539A TH 1601000539 A TH1601000539 A TH 1601000539A TH 1601000539 A TH1601000539 A TH 1601000539A TH 1601000539 A TH1601000539 A TH 1601000539A TH 1601000539 A TH1601000539 A TH 1601000539A
Authority
TH
Thailand
Prior art keywords
tumor therapy
vaccine components
divalent vaccine
divalent
components
Prior art date
Application number
TH1601000539A
Other languages
Thai (th)
Other versions
TH169737A (en
Inventor
รามีเรซ เบอลินด้า อีเกิลเซียส รีเวร่า อาเรียนน่า กูทีเอร์เรซ เปเรซ อเมเลีย กอนซาเลซ ซูอาเรซ นาร์จารา ซานเซซ
Original Assignee
เซ็นโทร เดอ อินมูโนโลเจีย โมเลคูลาร์
Filing date
Publication date
Application filed by เซ็นโทร เดอ อินมูโนโลเจีย โมเลคูลาร์ filed Critical เซ็นโทร เดอ อินมูโนโลเจีย โมเลคูลาร์
Publication of TH1601000539A publication Critical patent/TH1601000539A/en
Publication of TH169737A publication Critical patent/TH169737A/en

Links

TH1601000539A 2014-08-01 Divalent vaccine composition and their use for tumor therapy TH169737A (en)

Publications (2)

Publication Number Publication Date
TH1601000539A true TH1601000539A (en) 2017-10-27
TH169737A TH169737A (en) 2017-10-27

Family

ID=

Similar Documents

Publication Publication Date Title
DK3212670T3 (en) COMBINATION THERAPY AGAINST CANCER
DK3240801T3 (en) COMBINATION TUMOR IMMUNERAPY
GB201519858D0 (en) Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
BR112017002511A2 (en) therapeutic pad systems and methods
DK3590543T3 (en) Medical dressing
GB201403093D0 (en) Therapeutic compounds and their use
GB201418868D0 (en) Image-guided radiation therapy
DK3107563T3 (en) GLYCOM TARGETED THERAPEUTIC AGENTS
MA46378A (en) THERAPEUTIC HPV16 VACCINES
DK3095798T3 (en) IMMUNITY-ENHANCING THERAPEUTIC VACCINE AGAINST HPV AND RELATED DISEASES
BR112016027041A2 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
KR20180084772A (en) Combination Therapy for Cancer Treatment
DK3198009T3 (en) ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE
MA39483A (en) TARGET THERAPEUTIC AGENTS
IL250990A0 (en) Human therapeutic agents
SG11201701035SA (en) Cancer diagnosis and therapy
DK3215607T3 (en) PHAG THERAPY
DK3393478T3 (en) combination therapy
IL247325A0 (en) Therapeutic methods employing noribogaine and related compounds
DK3188599T3 (en) MEDICAL TREATMENTS BASED ON ANAMORELINE
DE112015001144A5 (en) therapy device
DK3277325T3 (en) COMBINATION IMMUNE THERAPY FOR CANCER
TH1601000539A (en) Divalent vaccine components and their use for tumor therapy
BR112018002732A2 (en) Tumor medical treatment agent
ES1149411Y (en) Heated therapeutic bandage